Fairvalue-Calculator Fairvalue-Calculator
EN DE

SOPHiA GENETICS SA (SOPH) Fair Value & Analysis

Healthcare · US · Market cap $447M

Price$5.23
Fair Value$2.53
Upside-51.6%
Quality95/100
Evidence: Low Range $1.90 – $3.16

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

SOPHiA GENETICS SA (SOPH) currently trades at $5.23, while our model-based Fair Value estimate is $2.53 — implying the stock looks roughly 51.6% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom. The company was incorporated in 2011 and is based in Rolle, Switzerland.

Open the full interactive analysis →

Similar stocks

Veeva Systems Inc (VEEV) -37% Pro Medicus Limited (PME) -79% BrightSpring Health Services, Inc (BTSG) -61% Tempus AI, Inc (TEM) -74% HealthEquity, Inc (HQY) -39% M3, Inc (MTHRY) +48%

Frequently asked questions

Is SOPHiA GENETICS SA (SOPH) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $2.53 versus a price of $5.23 — about −52% (overvalued). Model-based estimate, not financial advice.
What is the fair value of SOPH?
Our 21-model fair value for SOPHiA GENETICS SA is $2.53 (as of Jun 24, 2026), built from audited fundamentals. The current price is $5.23.
What is the quality score of SOPH?
SOPHiA GENETICS SA has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.